The investigational endoscopic procedure may help patients maintain weight loss or lose more weight 3 months after GLP-1 receptor agonist therapy discontinuation.
CapsoVision, a medical device developer, submitted an application Nov. 6 to the FDA requesting breakthrough device designation for its CapsoCam UGI capsule, aimed at detecting early-stage pancreatic ...
Dr Florian Jaeckle discusses how machine learning models can enhance the speed and accuracy of coeliac disease diagnosis from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback